Matthew C. Kiernan
Matthew C. Kiernan publishes mostly in Neurology, Cellular and Molecular Neuroscience and Genetics, on topics such as Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research and Peripheral Neuropathies and Disorders.
- World rank
- #133,917 of 7,710,434 ranked researchers
- Rank in Australia
- #4,562 of 140,210
- Works
- 987
- Citations
- 44k
- Citations per work
- 44.2
What does Matthew C. Kiernan research?
Matthew C. Kiernan's work is mostly in Medicine (43%), Neuroscience (15%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences42643.2%
- Medicine42643.2%
- Everything else35836.3%
- Life Sciences20220.5%
- Neuroscience15215.4%
- Biochemistry, Genetics and Molecular Biology505.1%
- 1Neurology31% of their works
- 2Cellular and Molecular Neuroscience9% of their works
- 3Genetics8% of their works
- 4Neurology7% of their works
- 5Molecular Biology5% of their works
- 6Physiology4% of their works
Research topics
- Amyotrophic Lateral Sclerosis Research
- Neurogenetic and Muscular Disorders Research
- Peripheral Neuropathies and Disorders
- Genetic Neurodegenerative Diseases
- Transcranial Magnetic Stimulation Studies
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Cancer Treatment and Pharmacology
Which keywords describe Matthew C. Kiernan's research?
The keywords of their largest research topics: Neurodegeneration, FUS/TLS, TDP-43, Mitochondrial Dysfunction, SMN1, Spinal Muscular Atrophy, Neurological Disorders and Parkinson's Disease.
- Taxanes
- Subthalamic Nucleus
- a-Synuclein
- Transcranial Magnetic Stimulation
- Protein Aggregation
- Guillain-Barré Syndrome
- Parkinson's Disease
- Spinal Muscular Atrophy
- Mitochondrial Dysfunction
- FUS/TLS
- Neurodegeneration
- TDP-43
- SMN1
- Neurological Disorders
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Huntington's Disease
- Transcranial Direct Current Stimulation
- Dopaminergic Neurons
- Deep Brain Stimulation
- Chemotherapy-Induced Peripheral Neuropathy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Neurodegeneration5352 topics
- FUS/TLS4411 topic
- TDP-434411 topic
- Mitochondrial Dysfunction2002 topics
- SMN11991 topic
- Spinal Muscular Atrophy1991 topic
- Neurological Disorders1852 topics
- Parkinson's Disease1572 topics
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy1221 topic
- Guillain-Barré Syndrome1221 topic
- Huntington's Disease1061 topic
- Protein Aggregation1061 topic
- Transcranial Direct Current Stimulation951 topic
- Transcranial Magnetic Stimulation951 topic
- Dopaminergic Neurons941 topic
- a-Synuclein941 topic
- Deep Brain Stimulation631 topic
- Subthalamic Nucleus631 topic
- Chemotherapy-Induced Peripheral Neuropathy601 topic
- Taxanes601 topic
Where does Matthew C. Kiernan work?
Matthew C. Kiernan's main affiliation in the publication record is The University of Sydney, Australia.
How many publications and citations does Matthew C. Kiernan have?
OpenAlex counts 987 works and 43,612 citations for Matthew C. Kiernan, an h-index of 105, ranking #133,917 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Matthew C. Kiernan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.